MoneyWorks4Me

Bharat Parenterals - Quaterly Results

08 Aug 2024 Evaluate
The sales for the June 2024 quarter moved up 31.68% to Rs. 920.60 millions as compared to Rs. 699.10 millions during the corresponding quarter last year.Net Profit recorded in the quarter ended June 2024 rise to 37.01% to Rs. 121.80  millions  compared to R. 88.90 millions in corresponding previous quarter.Operating profit for the quarter ended June 2024 rose to 188.80 millions as compared to 143.50 millions of corresponding quarter ended June 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 920.60 699.10 31.68 920.60 699.10 31.68 2541.60 2179.80 16.60
Other Income 39.00 28.60 36.36 39.00 28.60 36.36 119.50 188.40 -36.57
PBIDT 188.80 143.50 31.57 188.80 143.50 31.57 403.90 402.10 0.45
Interest 10.20 8.80 15.91 10.20 8.80 15.91 31.90 21.90 45.66
PBDT 178.60 134.70 32.59 178.60 134.70 32.59 372.00 380.20 -2.16
Depreciation 16.10 15.10 6.62 16.10 15.10 6.62 64.00 58.50 9.40
PBT 162.50 119.60 35.87 162.50 119.60 35.87 308.00 321.70 -4.26
TAX 40.70 30.70 32.57 40.70 30.70 32.57 82.10 78.30 4.85
Deferred Tax -2.75 -1.40 96.43 -2.75 -1.40 96.43 -4.50 -5.70 -21.05
PAT 121.80 88.90 37.01 121.80 88.90 37.01 225.90 243.40 -7.19
Equity 65.24 57.75 12.97 65.24 57.75 12.97 58.20 57.70 0.87
PBIDTM(%) 20.51 20.53 -0.09 20.51 20.53 -0.09 15.89 18.45 -13.85
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..